Literature DB >> 12428380

Evaluation of T factor, surgical method, and prognostic factors in central type lung cancer.

Makoto Saito1, Kinya Furukawa, Toyoaki Miura, Harubumi Kato.   

Abstract

OBJECTIVE: We report our experience in the diagnosis and surgical treatment of central type lung cancer (CTLC) and discuss the prognostic significance of clinicopathological factors including the T factor.
METHODS: Subjects were 151 patients with CTLC undergoing surgery from 1984 to 1999. Surgical procedures include lobectomy in 111, pneumonectomy in 35, and segmentectomy in 5. Bronchoplasty was done in 44, including sleeve lobectomy in 33, carinal resection in 8, and bronchoplasty without resection of pulmonary parenchyma in 3. Data on CTLC was compared to that on peripheral lung cancer during the same period.
RESULTS: Compared to peripheral tumors, central lung tumors showed a higher ratio in male gender, pN1 in pN factors, squamous cell carcinoma in histology, and pneumonectomy and bronchoplasty in surgery. No statistical differences were seen between groups in surgical outcome, mean age, distribution pattern in pT factors, and extended surgery. The positive predictive cT factor has improved. No significant difference was seen in 5-year survival based on 8 factors--period, cT factors, tumor histology, bronchoplasty, extended surgery, cellular atypia, additional chemotherapy, and radiotherapy. Five-year survival differed significantly for 12 other factors--pT, cN, and pN factors; surgical method; number of resected organs in extended surgery; curability (complete/incomplete); tumor size; N1 and N2 station metastasis; p factor, and blood vessel and lymphatic invasion. Multivariable analysis indicated only 2 independent prognostic factors--cN and p factor.
CONCLUSIONS: CTLC appears to belong to a subgroup other than peripheral tumors, requiring a more accurate diagnosis of cT factors, particularly in the proximal bronchus, because cT and cN factors are the only 2 used preoperatively.

Entities:  

Mesh:

Year:  2002        PMID: 12428380     DOI: 10.1007/bf02913174

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  14 in total

1.  Prognostic comparison between peripheral and central types of squamous cell carcinoma of the lung in patients undergoing surgical resection.

Authors:  Y Mizushima; R Yamashita; Y Kusajima; S Sugiyama
Journal:  Oncol Rep       Date:  2000 Mar-Apr       Impact factor: 3.906

Review 2.  Staging classification committee.

Authors:  R Ginsberg; J Cox; M Green; H Bulzebruck; D Grunenwald; P Harper; J Jett; T LeChevalier; F Mornex; C Scott; R Tsuchiya
Journal:  Lung Cancer       Date:  1997-06       Impact factor: 5.705

3.  Proximal bronchial extension with special reference to tumor localization in non-small cell lung cancer.

Authors:  M Kara; S Dizbay Sak; D Orhan; S Kavukçu
Journal:  Eur J Cardiothorac Surg       Date:  2001-08       Impact factor: 4.191

4.  Bronchoplastic and angioplastic techniques in the treatment of bronchogenic carcinoma.

Authors:  G Maggi; C Casadio; F Pischedda; R Cianci; E Ruffini; P Filosso
Journal:  Ann Thorac Surg       Date:  1993-06       Impact factor: 4.330

5.  Carinal reconstruction.

Authors:  H C Grillo
Journal:  Ann Thorac Surg       Date:  1982-10       Impact factor: 4.330

6.  Biological characterization of central and peripheral primary non small cell lung cancers (NSCLC).

Authors:  N M Malara; A Sgambato; P Granone; G Flamini; S Margaritora; A Boninsegna; A Cesario; D Galetta; Q Yang; A Cittadini
Journal:  Anticancer Res       Date:  1999 May-Jun       Impact factor: 2.480

Review 7.  Detection and localization of early lung cancer by imaging techniques.

Authors:  S Lam; C MacAulay; B Palcic
Journal:  Chest       Date:  1993-01       Impact factor: 9.410

8.  Tracheal sleeve pneumonectomy for bronchogenic carcinoma.

Authors:  G C Roviaro; F Varoli; C Rebuffat; S M Scalambra; C Vergani; E Sibilla; L Palmarini; G Pezzuoli
Journal:  J Thorac Cardiovasc Surg       Date:  1994-01       Impact factor: 5.209

9.  Management of anastomotic complications after sleeve lobectomy for lung cancer.

Authors:  K Kawahara; S Akamine; T Takahashi; A Nakamura; M Muraoka; H Tsuji; S Hara; Y Tagawa; H Ayabe; M Tomita
Journal:  Ann Thorac Surg       Date:  1994-06       Impact factor: 4.330

10.  One hundred and one cases of bronchoplasty for primary lung cancer.

Authors:  N Tsubota; M Yoshimura; A Murotani; Y Miyamoto; Y Matoba
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

View more
  4 in total

Review 1.  Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research.

Authors:  Eugenia Vlaskou Badra; Michael Baumgartl; Silvia Fabiano; Aurélien Jongen; Matthias Guckenberger
Journal:  Transl Lung Cancer Res       Date:  2021-04

2.  SBRT for centrally localized NSCLC - What is too central?

Authors:  J Roesch; C Panje; F Sterzing; F Mantel; U Nestle; N Andratschke; M Guckenberger
Journal:  Radiat Oncol       Date:  2016-12-03       Impact factor: 3.481

3.  Stereotactic body radiotherapy for centrally-located lung tumors with 56 Gy in seven fractions: A retrospective study.

Authors:  Shuri Aoki; Hideomi Yamashita; Akihiro Haga; Takeshi Ota; Wataru Takahashi; Sho Ozaki; Kanabu Nawa; Toshikazu Imae; Osamu Abe; Keiichi Nakagawa
Journal:  Oncol Lett       Date:  2018-07-23       Impact factor: 2.967

4.  Clinical significance and role of lymphatic vessel invasion as a major prognostic implication in non-small cell lung cancer: a meta-analysis.

Authors:  Jun Wang; Baocheng Wang; Weipeng Zhao; Yan Guo; Hong Chen; Huili Chu; Xiuju Liang; Jingwang Bi
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.